C4 Therapeutics, Inc. CCCC
2.48 USD +0.04 (+1.64%)
Regular-session close
2.37 -0.11 -4.42%
After hours · Nov 20, 4:22 PM ET
2.32 Day range 2.55
1.69 52-week range 5.17
- YTD
- +29.84%
- 1 year
- +4.20%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 35.95M | 35.58M | 20.76M | 31.10M | 45.78M | |
| 35.95M | 35.58M | 20.76M | 31.10M | 45.78M | |
| -115.22M | -119.61M | -139.03M | -129.53M | -82.13M | |
| -104.99M | -105.32M | -132.49M | -128.18M | -83.89M | |
| -1.27 | -1.52 | -2.67 | -2.62 | -1.82 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 78.05M | 58.94M | 130.03M | 33.03M | 79.40M | |
| 359.07M | 349.60M | 376.45M | 430.84M | 506.76M | |
| 102.49M | 133.62M | 130.34M | 141.61M | 117.16M | |
| 59.98M | 65.76M | 70.98M | 87.15M | 42.88M | |
| 256.59M | 215.99M | 246.11M | 289.23M | 389.61M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -98.69M | -65.16M | -106.84M | -105.94M | -86.97M | |
| -8.60M | -51.27M | 158.35M | 58.42M | -189.34M | |
| 126.40M | 45.34M | 45.49M | 1.15M | 171.40M | |
| -607.00K | -180.00K | -1.71M | -5.50M | -1.28M | |
| 19.10M | -71.09M | 97.00M | -46.37M | -104.90M |
